Kenneth G Saag

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi Short-term and long-term safety of glucocorticoids in rheumatoid arthritis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 51020th Street South, Birmingham, AL 35213, USA
    Bull NYU Hosp Jt Dis 70:21-5. 2012
  2. ncbi Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States
    Kenneth G Saag
    Center for Education and Research on Therapeutics CERTs, Center for Outcomes Effectiveness Research and Education COERE, and Center for Clinical and Translational Sciences CCTS, University of Alabama at Birmingham, Birmingham, AL, USA
    Contemp Clin Trials 33:1211-6. 2012
  3. ncbi Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial
    Kenneth G Saag
    University of Alabama at Birmingham
    Arthritis Rheum 60:3346-55. 2009
  4. ncbi The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs
    Fausto G Patino
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, 35294 3408, USA
    Arthritis Rheum 49:293-9. 2003
  5. ncbi Progress in osteoporosis and fracture prevention: focus on postmenopausal women
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294 3708, USA
    Arthritis Res Ther 11:251. 2009
  6. ncbi Prevention of glucocorticoid-induced osteoporosis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL, USA
    South Med J 97:555-8. 2004
  7. ncbi Glucocorticoid-induced osteoporosis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 1813 Sixth Avenue South, Birmingham, AL 35294 3296, USA
    Endocrinol Metab Clin North Am 32:135-57, vii. 2003
  8. ncbi Recent advances in the epidemiology of gout
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294 3408, USA
    Curr Rheumatol Rep 7:235-41. 2005
  9. ncbi Glucocorticoid use in rheumatoid arthritis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, University of Alabama at Birmingham, MEB 625, 1813 Sixth Avenue South, Birmingham, AL 35294 3296, USA
    Curr Rheumatol Rep 4:218-25. 2002
  10. ncbi Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Kenneth G Saag
    University of Alabama at Birmingham, Birmingham 35294 3408, USA
    N Engl J Med 357:2028-39. 2007

Detail Information

Publications123 found, 100 shown here

  1. ncbi Short-term and long-term safety of glucocorticoids in rheumatoid arthritis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 51020th Street South, Birmingham, AL 35213, USA
    Bull NYU Hosp Jt Dis 70:21-5. 2012
    ..Several new studies have contributed to an improved understanding of these associations and they are reviewed here along with highlights from the older body of literature examining these important outcomes...
  2. ncbi Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States
    Kenneth G Saag
    Center for Education and Research on Therapeutics CERTs, Center for Outcomes Effectiveness Research and Education COERE, and Center for Clinical and Translational Sciences CCTS, University of Alabama at Birmingham, Birmingham, AL, USA
    Contemp Clin Trials 33:1211-6. 2012
    ..Testing and adaptation of such innovations to PCT are anticipated to improve the public health value of these increasingly important studies...
  3. ncbi Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial
    Kenneth G Saag
    University of Alabama at Birmingham
    Arthritis Rheum 60:3346-55. 2009
    ..To compare the bone anabolic drug teriparatide (20 microg/day) with the antiresorptive drug alendronate (10 mg/day) for treating glucocorticoid-induced osteoporosis (OP)...
  4. ncbi The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs
    Fausto G Patino
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, 35294 3408, USA
    Arthritis Rheum 49:293-9. 2003
    ..To examine the effects of physician specialty and comorbidities on cyclooxygenase 2-selective nonsteroidal antiinflammatory drugs (NSAIDs; coxibs) utilization...
  5. ncbi Progress in osteoporosis and fracture prevention: focus on postmenopausal women
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294 3708, USA
    Arthritis Res Ther 11:251. 2009
    ..Emerging therapeutic options that target molecules of bone metabolism indicate that the next decade should offer even greater promise for further improving our diagnostic and treatment approaches...
  6. ncbi Prevention of glucocorticoid-induced osteoporosis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL, USA
    South Med J 97:555-8. 2004
    ..This article discusses an evidence-based approach to the prevention of glucocorticoid-induced osteoporosis...
  7. ncbi Glucocorticoid-induced osteoporosis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 1813 Sixth Avenue South, Birmingham, AL 35294 3296, USA
    Endocrinol Metab Clin North Am 32:135-57, vii. 2003
    ..This article focuses on areas of continued controversies, including the epidemiology and pathogenesis of GIOP, specification of a "safe" dose, methods for diagnosis of GIOP, and an evidence-based approach for GIOP prevention...
  8. ncbi Recent advances in the epidemiology of gout
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294 3408, USA
    Curr Rheumatol Rep 7:235-41. 2005
    ..The importance of hyperuricemia on health considerations beyond the musculoskeletal system is an area worthy of even more study...
  9. ncbi Glucocorticoid use in rheumatoid arthritis
    Kenneth G Saag
    Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, University of Alabama at Birmingham, MEB 625, 1813 Sixth Avenue South, Birmingham, AL 35294 3296, USA
    Curr Rheumatol Rep 4:218-25. 2002
    ..The correct identification of patients at high risk for bone complications and the institution of appropriate preventive measures may partially attenuate this adverse outcome...
  10. ncbi Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Kenneth G Saag
    University of Alabama at Birmingham, Birmingham 35294 3408, USA
    N Engl J Med 357:2028-39. 2007
    ..Studies of anabolic therapy in patients who are receiving long-term glucocorticoids and are at high risk for fracture are lacking...
  11. ncbi Trends in prevention of glucocorticoid-induced osteoporosis
    Kenneth G Saag
    UAB Center for Education and Research on Musculoskeletal Disorders, University of Alabama at Birmingham, 35294, USA
    J Rheumatol 33:1651-7. 2006
    ..To determine longitudinal patterns and predictors for the utilization of bone mass measurements and anti-osteoporotic medications in the prevention of glucocorticoid-induced osteoporosis...
  12. ncbi Epidemiology, risk factors, and lifestyle modifications for gout
    Kenneth G Saag
    UAB Center for Education and Research CERTs on Therapeutics of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Arthritis Res Ther 8:S2. 2006
    ..The increasing prevalence of gout worldwide indicates that there is an urgent need for improved efforts to identify patients with hyperuricemia early in the disease process, before the clinical manifestations of gout become apparent...
  13. ncbi Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics
    Kenneth G Saag
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, 35294 3296, USA
    Arthritis Rheum 51:337-49. 2004
    ..To develop systematically validated quality indicators (QIs) addressing analgesic safety...
  14. ncbi Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Med Care 47:334-41. 2009
    ..We tested whether adding information on compliance with other drugs used to treat chronic, asymptomatic conditions would improve the predictive ability of administrative data to identify adherent individuals...
  15. ncbi Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, 1600 7th Avenue South, CPP 210, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:2773-80. 2012
    ..To compare the incidence of hospitalized bacterial infections among children with and children without juvenile idiopathic arthritis (JIA) and to examine the effects of selected medications...
  16. ncbi Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users
    Jeffrey R Curtis
    Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Pharmacoepidemiol Drug Saf 15:710-8. 2006
    ..Use of pharmacy data alone is unlikely to underestimate quality of osteoporosis care, but different intervals of pharmacy data have important implications on the ability to identify current users of osteoporosis medications...
  17. ncbi Prevention and treatment of glucocorticoid-induced osteoporosis
    Jeffrey R Curtis
    University of Alabama at Birmingham, FOT 840, 510 20th Street South, Birmingham, AL 35294, USA
    Curr Osteoporos Rep 5:14-21. 2007
    ..New approaches to evidence implementation are being tested to improve the quality of osteoporosis care and decrease fracture risk among long-term glucocorticoid users...
  18. ncbi Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists
    Jeffrey R Curtis
    University of Alabama at Birmingham, AL, USA
    Arthritis Rheum 56:4226-7. 2007
  19. ncbi Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior
    Rachel B Fry
    University of Alabama at Birmingham, Birmingham, AL, USA
    Arthritis Rheum 57:1539-45. 2007
    ..Little is known about NSAID-related ethnic/racial disparities. We focused on differences in patient NSAID risk awareness, patient-doctor NSAID risk communication, and NSAID risk-avoidance behavior...
  20. ncbi Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis
    Jeffrey R Curtis
    Department of Medicine, University of Alabama, 510 20th Street South, FOT 805D, Birmingham, AL 35294, USA
    Arthritis Res Ther 13:R155. 2011
    ..We created and tested a claims-based algorithm to serve as a proxy for the clinical effectiveness of RA medications...
  21. ncbi Population-based assessment of adverse events associated with long-term glucocorticoid use
    Jeffrey R Curtis
    University of Alabama at Birmingham, 35294, USA
    Arthritis Rheum 55:420-6. 2006
    ..Physicians should be vigilant for glucocorticoid-related AEs and should counsel patients about possible risks, even among low-dose long-term users...
  22. ncbi Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL, USA
    Arthritis Care Res (Hoboken) 64:1480-9. 2012
    ..To evaluate whether rates of serious infection with anti-tumor necrosis factor (anti-TNF) therapy in rheumatoid arthritis (RA) patients differ in magnitude by specific drugs and patient characteristics...
  23. ncbi Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data
    Ted R Mikuls
    Department of Medicine, University of Nebraska Medica Center and Omaha VA Medical Center, Omaha, NE 68198 3025, USA
    J Natl Med Assoc 97:1155-60. 2005
    ..To examine the prevalence of osteopenia and/or osteoporosis among African Americans with early rheumatoid arthritis (RA) and to assess the effect of using race/ethnicity-specific normative data...
  24. ncbi Health services utilization after fractures: evidence from Medicare
    David J Becker
    Department of Health Care Organization and Policy, University of Alabama at Birmingham, 1665 University Blvd, RPHB 330H, Birmingham, AL 35294, USA
    J Gerontol A Biol Sci Med Sci 65:1012-20. 2010
    ..Postfracture utilization of health care services represents an alternative measure of the resource costs associated with these fractures...
  25. ncbi Management of osteoporosis among home health and long-term care patients with a prior fracture
    Amy H Warriner
    University of Alabama at Birmingham, USA
    South Med J 102:397-404. 2009
    ....
  26. ncbi Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort
    Angelo L Gaffo
    Birmingham VA Medical Center 700 South 19th Street, Birmingham, AL 35233, USA
    Arthritis Res Ther 14:R4. 2012
    ..We tested this hypothesis in a bi-racial cohort of younger African-American and white men and women...
  27. ncbi Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:1263-71. 2012
    ..To determine the relative rates of incident malignancy among children with juvenile idiopathic arthritis (JIA) with respect to treatment as compared to children without JIA...
  28. ncbi Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases
    Jie Zhang
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, 35294, USA
    JAMA 308:43-9. 2012
    ..The safety and effectiveness of the vaccine are unclear for these patients...
  29. ncbi Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes
    Jie Zhang
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Bone Miner Res 27:858-64. 2012
    ..The reduction in DXA reimbursement was associated with a decrease in the number of DXAs performed in physician offices and fewer physician offices that provided DXA services...
  30. ncbi Health and happiness among older adults: a community-based study
    Erik Angner
    Department of Philosophy, University of Alabama at Birmingham, Birmingham, AL 35294 1260, USA
    J Health Psychol 14:503-12. 2009
    ..The results, robust to common method bias, suggest that subjective health measures are better predictors of happiness than objective measures are, except for conditions that disrupt daily functioning or are associated with social stigma...
  31. ncbi Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients
    Jeffrey R Curtis
    University of Alabama at Birmingham, 35294, USA
    Arthritis Rheum 52:2485-94. 2005
    ....
  32. ncbi Identification and validation of vertebral compression fractures using administrative claims data
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Med Care 47:69-72. 2009
    ..Vertebral compression fractures (VCFs) are the most common type of osteoporotic fracture. Administrative claims data might be useful to identify VCFs, but this approach to case finding has received limited evaluation...
  33. ncbi Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham 35294, USA
    J Gen Intern Med 24:956-62. 2009
    ..Undertreatment of osteoporosis has been recognized as a common problem in selected patient subgroups. However, primary prevention has been hampered by limited risk assessment tools that can be applied to large populations...
  34. ncbi Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices
    Fausto G Patino
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294-3408, USA
    J Rheumatol 30:2680-8. 2003
    ..CONCLUSION: While rheumatologists and internists trended toward more CBC and creatinine testing, visit frequency, duration of NSAID use, and comorbidities were the factors most consistently associated with safety monitoring...
  35. ncbi Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Diseases, University of Alabama at Birmingham, AL 35294, USA
    Arch Intern Med 167:591-6. 2007
    ....
  36. ncbi Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population
    Jeffrey R Curtis
    University of Alabama at Birmingham, AL, USA
    Arthritis Care Res (Hoboken) 64:1054-60. 2012
    ..To evaluate adherence to drug therapy among new users of zoledronate and intravenous (IV) ibandronate among US Medicare enrollees...
  37. ncbi Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Clin Densitom 11:568-74. 2008
    ..Greater guidance and transparency in coding policies are needed to ensure that DXA as a covered service is reimbursed for Medicare beneficiaries with the appropriate indications...
  38. ncbi Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Am Med Dir Assoc 11:584-91. 2010
    ..Among US Medicare beneficiaries, we evaluated the risk for second fracture versus death in the 5 years following a hip, clinical vertebral, and wrist/forearm fracture...
  39. ncbi The delivery of evidence-based preventive care for older Americans with arthritis
    Jeffrey R Curtis
    Department of Medicine, University of Alabama, Birmingham, Birmingham, AL 35294, USA
    Arthritis Res Ther 12:R144. 2010
    ..We evaluated the proportion of older Americans with RA, psoriatic arthritis (PsA), and osteoarthritis (OA) receiving these services and the specialty of the providers delivering this care...
  40. ncbi Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients
    Nivedita M Patkar
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL 35294 3408, USA
    J Clin Epidemiol 62:321-7, 327.e1-7. 2009
    ..To evaluate diagnostic properties of International Classification of Diseases, Version 9 (ICD-9) diagnosis codes and infection criteria to identify bacterial infections among rheumatoid arthritis (RA) patients...
  41. ncbi Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data
    Pongthorn Narongroeknawin
    Department of Medicine, University of Alabama, Birmingham, AL, USA
    J Clin Densitom 15:92-102. 2012
    ..These claims algorithms will be useful in future population-based observational studies to evaluate associations between osteoporosis medications and subtrochanteric and diaphyseal femoral fractures...
  42. ncbi Osteoporosis in the home health care setting: A window of opportunity?
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Rheum 55:971-5. 2006
  43. ncbi Biologics and heart failure in rheumatoid arthritis: are we any wiser?
    Maria I Danila
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Curr Opin Rheumatol 20:327-33. 2008
    ....
  44. ncbi Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users
    Jeffrey R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Bone Miner Res 23:1435-41. 2008
    ..These results provide estimates of absolute fracture effectiveness across age subgroups and fracture types that have been minimally evaluated in clinical trials and may be useful for future cost-effectiveness studies...
  45. ncbi Racial disparities in osteoporosis prevention in a managed care population
    Amy S Mudano
    Department of Medicine and Center for Education and Research on Therapeutics of Musculoskeletal Disorders, Division of Continuing Medical Education, University of Alabama at Birmingham, 35294-3408, USA
    South Med J 96:445-51. 2003
    ..CONCLUSION: Compared with whites, black women reported significantly less BMD testing and prescription and nonprescription osteoporosis therapy. This disparity was not fully explained by other demographic or risk factor differences...
  46. ncbi A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Am J Manag Care 11:537-43. 2005
    ..Potentially contributing factors include high baseline performance (ceiling effect), dilution of the intervention effect by case mix and provider factors, nonreceipt of intervention materials, and diverse indications for lab tests...
  47. ncbi Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data
    Jeffrey R Curtis
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arthritis Care Res (Hoboken) 64:1855-63. 2012
    ....
  48. ncbi Improving osteoporosis care in high-risk home health patients through a high-intensity intervention
    Ryan C Outman
    Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, FOT 820, 1530 3rd Ave S, Birmingham, AL 35294, United States
    Contemp Clin Trials 33:206-12. 2012
    ..We developed and tested a multi-modal intervention, delivered in the home health care setting, aimed at increasing osteoporosis treatment rates to prevent fractures...
  49. ncbi Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35294, USA
    AIDS Res Hum Retroviruses 22:125-31. 2006
    ..Studies to examine ethnic variations in bone metabolism are necessary to devise optimal interventions...
  50. ncbi Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005
    Meredith L Kilgore
    Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Bone Miner Res 24:2050-5. 2009
    ..Further research is needed to ascertain other health conditions that are driving costs for Medicare beneficiaries after fractures...
  51. ncbi Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists
    Jeffrey R Curtis
    University of Alabama at Birmingham, Center for Education and Research on Therapeutics, AL 35294, USA
    Arthritis Rheum 56:1125-33. 2007
    ..To evaluate the risk of serious bacterial infections associated with tumor necrosis factor alpha (TNFalpha) antagonists among rheumatoid arthritis (RA) patients...
  52. ncbi Recent trends in hip fracture rates by race/ethnicity among older US adults
    Nicole C Wright
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
    J Bone Miner Res 27:2325-32. 2012
    ..Further research is needed to understand mechanisms responsible for declining rates in some and not others, as hip fractures continue to be a major problem among the elderly. © 2012 American Society for Bone and Mineral Research...
  53. ncbi Longitudinal trends in use of bone mass measurement among older americans, 1999-2005
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Bone Miner Res 23:1061-7. 2008
    ..Given the importance of central DXA to assess the risk of osteoporotic fractures, strategies to increase central DXA use to test at-risk persons are warranted...
  54. ncbi The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
    Jeffrey R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Ann Rheum Dis 70:1401-6. 2011
    ..This study evaluated the incidence of hospitalised infections among rheumatoid arthritis (RA) patients starting or switching various biological agents...
  55. ncbi From fracture risk prediction to evaluating fracture patterns: recent advances in the epidemiology of osteoporosis
    Nicole C Wright
    Department of Epidemiology, University of Alabama at Birmingham, 35294, USA
    Curr Rheumatol Rep 14:205-11. 2012
    ..We also discuss recent evaluations of secular trends in fracture incidence...
  56. ncbi Association of infections and tuberculosis with antitumor necrosis factor alpha therapy
    Nivedita M Patkar
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294 3408, USA
    Curr Opin Rheumatol 20:320-6. 2008
    ..We present recent literature on this topic with a focus on clinical applications of this new data...
  57. ncbi The epidemiology of glucocorticoid-associated adverse events
    Allyson K McDonough
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35213, USA
    Curr Opin Rheumatol 20:131-7. 2008
    ..The purpose of this review is to provide an update on the most recent literature regarding glucocorticoid use and associated adverse events...
  58. ncbi The association of race/ethnicity with the receipt of traditional and alternative arthritis-specific health care
    Ted R Mikuls
    Department of Medicine, Section of Rheumatology and Immunology, University of Nebraska Medical Center and the Omaha VA Medical Center, Omaha, Nebraska, USA
    Med Care 41:1233-9. 2003
    ....
  59. ncbi Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture
    Ted R Mikuls
    Department of Medicine, Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3025, USA
    J Rheumatol 32:870-5. 2005
    ..To examine potential racial/ethnic disparities in osteoporosis care among community-dwelling older women with self-reported arthritis and previous fracture...
  60. ncbi Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists
    J R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, The University of Alabama at Birmingham, Birmingham, AL, USA
    Rheumatology (Oxford) 46:1688-93. 2007
    ..HF clinical trials of these agents were stopped early due to futility or worsening of existing HF. A potential association between etanercept and infliximab and new onset HF has been studied minimally at a population level...
  61. ncbi Gout epidemiology: results from the UK General Practice Research Database, 1990-1999
    T R Mikuls
    Department of Medicine, University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, USA
    Ann Rheum Dis 64:267-72. 2005
    ..CONCLUSION: Although gout is common in the UK, particularly among older men, the incidence of the disease seems to have remained stable during the 1990s...
  62. ncbi A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women
    Amy H Warriner
    Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Bone Miner Res 27:2603-10. 2012
    ..This simple approach may be an effective component of a multifaceted quality improvement program to increase rates of osteoporosis screening...
  63. ncbi Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?
    Angelo L Gaffo
    Birmingham VA Medical Center, Birmingham, AL 35294, USA
    Am J Cardiovasc Drugs 12:1-6. 2012
    ....
  64. ncbi Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort
    Angelo L Gaffo
    Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, USA
    Ann Rheum Dis 69:1965-70. 2010
    ..To investigate if beer, liquor (spirits), wine and total alcohol intakes have different associations with serum urate (SU) concentrations at different ages in a cohort of young men and women...
  65. ncbi Developing a provisional definition of flare in patients with established gout
    Angelo L Gaffo
    Birmingham VA Medical Center and University of Alabama at Birmingham, AL, USA
    Arthritis Rheum 64:1508-17. 2012
    ..Various nonvalidated criteria for disease flare have been used in studies of gout. Our objective was to develop empirical definitions for a gout flare from patient-reported features...
  66. ncbi Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system
    Ted R Mikuls
    Department of Medicine, University of Nebraska Medical Center, Omaha, USA
    J Rheumatol 33:562-6. 2006
    ..Physician prescribing practices are a potential target for quality improvement interventions in gout care...
  67. ncbi Bone mineral density changes within six months of renal transplantation
    Ted R Mikuls
    Section of Rheumatology and Immunology, Department of Medicine, University of Nebraska Medical Center, USA
    Transplantation 75:49-54. 2003
    ..Lumbar bone loss seemed to be mediated primarily by glucocorticoid dose and a history of alcohol use...
  68. ncbi Treatment of rheumatoid arthritis
    Angelo Gaffo
    Center for Education and Research and Therapeutics of Musculoskeletal Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
    Am J Health Syst Pharm 63:2451-65. 2006
    ....
  69. ncbi Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies
    Jie Zhang
    Department of Epidemiology and Health Services Comparative Effectiveness Research Training Program, University of Alabama at Birmingham, 1665 University Boulevard, RPHB 517B, Birmingham, AL 35294, USA
    Curr Rheumatol Rep 13:273-82. 2011
    ....
  70. ncbi Long-term safety concerns of antiresorptive therapy
    Jie Zhang
    Health Services Comparative Effectiveness Research Training Program, Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, RPHB 517B, Birmingham, AL 35294, USA
    Rheum Dis Clin North Am 37:387-400, vi. 2011
    ..This review summarizes studies examining the association between bisphosphonate use and these adverse outcomes, with a focus on large case series and controlled epidemiologic studies...
  71. ncbi Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?
    Gim Gee Teng
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, and Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, Birmingham, AL 35294 3708, USA
    Curr Osteoporos Rep 7:27-34. 2009
    ..Methods to improve quality of care in osteoporosis need to be multipronged, with emphasis on clinical process improvement and reliance on interdisciplinary teams. We review the growing literature on quality of care for osteoporosis...
  72. ncbi Pathophysiology, clinical presentation and treatment of gout
    Gim Gee Teng
    Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294-3296, USA
    Drugs 66:1547-63. 2006
    ....
  73. ncbi Osteoporosis: evaluation and treatment
    Sonia Bajaj
    Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294-3408, USA
    Curr Womens Health Rep 3:418-24. 2003
    ..This increasing range of treatment options allows better matching of therapy to patients...
  74. ncbi American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
    Kenneth G Saag
    University of Alabama, Birmingham, AL, USA
    Arthritis Rheum 59:762-84. 2008
  75. ncbi Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention
    Deborah A Levine
    Deep South Center on Effectiveness Research, An HSR and D REAP, Birmingham VA Medical Center, Birmingham, AL, USA
    J Am Med Dir Assoc 7:420-5. 2006
    ..Barriers prevent osteoporosis care in nursing homes. Successful interventions designed to circumvent these barriers benefit from target recipient input during development...
  76. ncbi Improving quality of care in osteoporosis: opportunities and challenges
    Gim Gee Teng
    Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294 3708, USA
    Curr Rheumatol Rep 10:123-30. 2008
    ..Recent studies have indicated that restructuring care at the system level is more likely to be successful, dependable, and durable than traditional quality improvement interventions focusing predominantly on physicians...
  77. ncbi Comorbidity in rheumatoid arthritis
    T R Mikuls
    Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Rheum Dis Clin North Am 27:283-303. 2001
    ..The next decade should prove to be an exciting time in RA management. Better identification, understanding, and management of RA comorbidities have great potential to improve quality of life and survival among our patients with RA...
  78. ncbi Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
    T Beukelman
    University of Alabama at Birmingham, Deep South Musculoskeletal Center for Education and Research on Therapeutics, Birmingham, AL 35294 3408, USA
    Osteoporos Int 21:1573-84. 2010
    ....
  79. ncbi Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research
    J R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Osteoporos Int 20:1921-7. 2009
    ..We found no significant clustering effect for common practice setting, suggesting that osteoporosis quality improvement (QI) efforts may be able to ignore this factor in designing QI interventions...
  80. ncbi Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study
    T R Mikuls
    Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 35294, USA
    Ann Rheum Dis 61:994-9. 2002
    ..To determine whether rheumatoid arthritis (RA) is associated with excess mortality among older women...
  81. ncbi Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, FOT 820, 510 20th Street South, 35294, USA
    Osteoporos Int 17:1268-74. 2006
    ..Newer strategies to promote long-term adherence are needed to improve osteoporosis therapeutic effectiveness...
  82. ncbi Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data
    H Cheng
    Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:1507-15. 2009
    ..Estimates of osteoporosis (OP) prevalence based on bone mineral density testing and fracture occurrence may be imprecise for small demographic groups. Medicare data are a useful supplemental source of information on OP...
  83. ncbi "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:1969-72. 2009
    ..Among these, 48% (vertebral) and 3% (hip) of the fractures were coded as pathologic. Only 25% and 66% of persons with these pathologic fractures had evidence for malignancy...
  84. ncbi The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:1553-61. 2009
    ..After adjusting for potentially confounding factors, travel distance was strongly associated with DXA testing. Rural residents were most strongly dependent on the availability of DXAs performed in physician offices...
  85. ncbi Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
    J R Curtis
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 19:1613-20. 2008
    ....
  86. ncbi Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs
    J R Curtis
    University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Arthritis Rheum 57:343-6. 2007
  87. ncbi RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
    J R Curtis
    Center for Education and Research on Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA
    Osteoporos Int 20:973-8. 2009
    ..We conclude that the agents have comparable efficacy...
  88. ncbi Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
    Angelo L Gaffo
    Birmingham VA Medical Center, 700 19th St S, Birmingham, AL 35233, USA
    Arthritis Res Ther 11:240. 2009
    ..In this review we present recently published data that study the association between hyperuricemia and selected cardiovascular diseases, with a final conclusion about the possibility of this association being causal...
  89. ncbi The effect of thiazolidinediones on BMD and osteoporosis
    Allyson K McDonough
    University of Alabama at Birmingham, Division of Clinical Immunology Rheumatology, FOT 820D, 1530 3rd Avenue South, Birmingham, AL 35294 3408, USA
    Nat Clin Pract Endocrinol Metab 4:507-13. 2008
    ....
  90. ncbi Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?
    Sumapa Chaiamnuay
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Rev Endocr Metab Disord 7:101-12. 2006
    ..Newer safety concerns about the use of bisphosphonates include osteonecrosis of the jaw and oversuppression of bone turnover. The optimal duration of bisphosphonate treatment has not been clearly established...
  91. ncbi Unbalanced regulation of over-the-counter analgesics: the lesser of two evils?
    Jeroan J Allison
    Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, Alberta, Canada
    Pharmacoepidemiol Drug Saf 15:410-1. 2006
  92. ncbi Management of hyperuricemia and gout in CKD
    Angelo L Gaffo
    Birmingham VA Medical Center, University of Alabama at Birmingham, AL, USA
    Am J Kidney Dis 52:994-1009. 2008
  93. ncbi Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks
    H B Townsend
    Center for Education and Research on Therapeutics of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham 35294-3408, USA
    Clin Exp Rheumatol 22:S77-82. 2004
    ..In this review we will examine the latest data supporting the benefits and risks of glucocorticoid use in RA...
  94. ncbi The cost of glucocorticoid-associated adverse events in rheumatoid arthritis
    M Pisu
    Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 1530 3rd Avenue North, Birmingham, AL 35294-3408, USA
    Rheumatology (Oxford) 44:781-8. 2005
    ..Patients, providers and policy makers should consider these potential costs of GAEs when making treatment decisions...
  95. ncbi Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis
    L B Hughes
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 415 Lyons Harrison Research Building, Birmingham, AL 35294 0007, USA
    Ann Rheum Dis 65:1213-8. 2006
    ..The anti-folate drug methotrexate (MTX) is commonly used to treat rheumatoid arthritis...
  96. ncbi Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women
    L A Criswell
    Rosalind Russell Medical Research Center for Arthritis, Department of Medicine, University of California, San Francisco, CA, USA
    Ann Rheum Dis 65:1163-7. 2006
    ..To determine whether the impact of tobacco exposure on rheumatoid arthritis (RA) risk is influenced by polymorphisms at the HLA-DRB1 and glutathione S-transferase M1 (GSTM1) loci...
  97. ncbi Impact of osteoporosis treatment adherence on fracture rates in North America and Europe
    Ethel S Siris
    Toni Stabile Osteoporosis Center, Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA
    Am J Med 122:S3-13. 2009
    ....
  98. ncbi Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study
    Ted R Mikuls
    University of Alabama at Birmingham, 35294-3296, USA
    Arthritis Rheum 46:83-91. 2002
    ..Further investigations of decaffeinated coffee and tea intake as arthritis risk factors are needed to verify these findings and explore their biologic basis...
  99. ncbi Samarium-153-EDTMP in the treatment of refractory rheumatoid arthritis
    T R Mikuls
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, USA
    Scand J Rheumatol 30:356-9. 2001
    ..Sm-153, at doses of 0.5 and 1.0 mCi/kg, is well tolerated but minimally effective in the treatment of refractory RA as measured using ACR response criteria...
  100. ncbi Challenges in defining and improving osteoporosis quality of care
    A Warriner
    Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294 3708, USA
    Clin Exp Rheumatol 25:142-6. 2007
    ..In order to overcome these barriers, interventions that can be widely disseminated, cost-effective and influential at multiple levels are needed...
  101. ncbi Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study
    A S Mudano
    Center for Education and Research on Therapeutics CERTs of Musculoskeletal Disorders, University of Alabama at Birmingham, Birmingham, AL 35294 3408, USA
    Osteoporos Int 20:819-26. 2009
    ..The risk of subsequent fracture was significantly greater among treatment patients, especially within 90 days of the procedure...